hotspot -WSS

hotspot

author：leisure time 2025-09-28 23:48:25 - browse：85395

A medical insurance document printed with the words "COPAY," "DEDUCTIBLE," "COINSURANCE," "NON-COVERED," next to a pen — coverage from STAT — Adobe

WASHINGTON — Insurers will have to count drug copay coupons toward deductibles and patient spending caps in most cases, after a Biden move in federal court on Tuesday.

Drug companies use copay coupons to help patients cover the cost of their drugs.

Before now, when drug companies helped patients pay their share of drug costs, insurers often didn’t count that assistance toward deductibles and out-of-pocket limits. In insurance jargon, this tactic is called a copay accumulator. Previously, the practice was only allowed when drug companies give coinsurance assistance for brand drugs with generic competition. The Trump administration let insurers use the tactic when cheaper generics were not available.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： The unintended consequences of overturning Roe v. Wade

WSS

Poor hospice wound care hurts patients and families

NYU radiologists take on the challenge of expensive MRI machines

Midwives could help bridge maternal health disparities in the U.S.

Astellas still sees hope in its gene therapy after four deaths

Senate bill would ban some hospital facility fees

Readout LOUD podcast: A CRISPR milestone, biotech mixology

leisure time

hotspot

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA's Woodcock to retire early next year

As demand for Covid shots wanes, Moderna seeks its next success

The unintended consequences of overturning Roe v. Wade

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

In key trial, Verve's treatment lowers cholesterol levels in patients

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Medical leaders decry Supreme Court decision on affirmative action

Congress must reauthorize a committee to support older Americans

leisure time

White House Covid adviser calls on docs to combat misinformation

White House Covid adviser calls on docs to combat misinformation

Neurocrine congenital adrenal hyperplasia trial succeeds

Astellas still sees hope in its gene therapy after four deaths

World's first CRISPR

Wegovy, Zepbound and weight loss drugs that preserve muscle

leisure time

explore

focus

Wikipedia